Text Messaging, Telephone, or In-Person Outpatient Visit to the Surgical Clinic: A Randomized Trial

J Surg Res. 2022 Dec:280:226-233. doi: 10.1016/j.jss.2022.07.013. Epub 2022 Aug 22.

Abstract

Introduction: Routine outpatient follow-up visits for surgical patients are a source of strain on health-care resources and patients. With the COVID-19 pandemic adding a new urgency to finding the safest follow-up arrangement, text message follow-up might prove an acceptable alternative to a phone call or an in-person clinic visit.

Methods: An open-label, three-arm, parallel randomized trial was conducted. The interventions were traditional in-person appointment, a telephone call, or a text message. The primary outcome was the number of postdischarge complications identified. The secondary outcomes were patient satisfaction with follow-up, future preference, default to follow-up, and preference to receiving medical information by text message.

Results: Two hundred eight patients underwent randomization: 50 in the in-person group, 80 in the telephone group, and 78 in the text message group. There was no difference in the number of reported complications: 5 (10%) patients in the in-person group, 7 (9%) patients in the text group, and 11 (14%) patients in the telephone group (P = 0.613). The preferred method of follow-up was by telephone (106, 61.6%). The least preferred was the in-person follow-up (15, 8.7%, P = 0.002), which also had the highest default rate (44%).

Conclusions: There was no evidence that text messages and telephone calls are unsafe and ineffective methods of follow-up. Although most patients are happy to receive results by text message, the majority of patients would prefer a telephone follow-up and are less likely to default by this method. Health-care systems should develop telehealth initiatives when planning health-care services in the wake of the COVID-19 pandemic.

Keywords: General surgery; Patient satisfaction; Quality improvement; Telemedicine; Text messaging.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aftercare
  • COVID-19* / epidemiology
  • Humans
  • Outpatients
  • Pandemics
  • Patient Discharge
  • Telephone
  • Text Messaging*